Sectors

INKT
MiNK Therapeutics, Inc.
11.10
2 x 8.08
2 x 14.60
bid
ask
-
0.33
2.87%
02:37 PM
timesize
Ytd-0.45%
1y-22.05%
11.10
day range
11.75
8.48
52 week range
16.98
Open11.51Prev Close11.43Low11.10High11.75Mkt Cap56.64M
Vol7.33KAvg Vol17.52KEPS-2.37P/EN/AForward P/E-1.17
Beta0.48Short Ratio1.10Inst. Own2.25%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1250-d Avg11.25200-d Avg11.411yr Est6.50
Income Statement
Operating Expenses3.22M
Research and Development Expense1.89M
Selling, General and Administrative Expense1.33M
Operating Income-3.22M
Net Income-3.13M
Net Income Common Stock-3.13M
Net Income Common Stock (USD)-3.13M
Consolidated Income-3.13M
Earnings per Basic Share-0.62
Earnings per Basic Share (USD)-0.62
Earnings per Diluted Share-0.62
Earning Before Interest & Taxes (EBIT)-3.13M
Earning Before Interest & Taxes (USD)-3.13M
Weighted Average Shares5.02M
Weighted Average Shares Diluted5.02M
Balance Sheet
Cash and Equivalents8.81M
Cash and Equivalents (USD)8.81M
Current Assets9.30M
Property, Plant & Equipment Net318.47K
Total Assets9.62M
Current Liabilities7.57M
Total Liabilities23.64M
Accumulated Retained Earnings (Deficit)-162.55M
Accumulated Other Comprehensive Income-699.89K
Shareholders Equity-14.03M
Shareholders Equity (USD)-14.03M
Assets Non-Current318.47K
Liabilities Non-Current16.07M
Trade and Non-Trade Payables19.99M
Cash Flow
Depreciation, Amortization & Accretion36.06K
Net Cash Flow from Financing1.37M
Net Cash Flow / Change in Cash & Cash Equivalents-718.70K
Issuance (Purchase) of Equity Shares1.37M
Net Cash Flow from Operations-2.08M
Effect of Exchange Rate Changes on Cash -2.04K
Share Based Compensation422.20K